Kaj Blennow, MD, PhD

Professors Kaj Blennow and Henrik Zetterberg direct a world-leading clinical and research unit that has 50 employees and publishes 150 papers per year on clinical neurochemistry (University of Gothenburg). Their work focuses on the use of cerebrospinal fluid and plasma biomarkers for the early diagnosis of neurodegenerative disorders, including Alzheimer´s disease, as well the development of biomarkers as predictors of functional/cognitive outcomes. They have built up a large research team and a very well-equipped laboratory for research on protein chemistry, immunoassays, proteomics and molecular biology. Together they have published more than 1400 original research papers in peer-reviewed journals, with more than 100000 citations.